...
首页> 外文期刊>Nagoya journal of medical science >Intrawound Vancomycin powder as the prophylaxis of surgical site infection after invasive spine surgery with a high risk of infection
【24h】

Intrawound Vancomycin powder as the prophylaxis of surgical site infection after invasive spine surgery with a high risk of infection

机译:伤口内万古霉素粉预防有创感染的脊柱外科手术后的手术部位感染

获取原文
           

摘要

Surgical site infections (SSIs) are one of the most serious complications in spine surgery. We investigated the efficacy of locally administered vancomycin (VCM) powder for prophylaxis on SSI after invasive spine surgery. We retrospectively studied 174 consecutive patients who underwent spine surgery. In patients of the VCM group (n = 81), VCM powder was administered in the wound before closing wound. Patients who did not receive VCM treatment were set as a control group (n = 93). We compared the patients’ background, operation time, intraoperative blood loss, usage of implants, presence of deep SSI, and side effects between the two groups. There were no significant differences between the groups in age, gender, and BMI. The operation time and the intraoperative blood loss were longer and greater in the VCM group than in the control group (P < 0.005, P < 0.001, respectively). Implants were used in 85% of the VCM group, and in 31% of the control group (P < 0.001). Deep SSI was not observed in the VCM group, whereas it was observed in 4 patients in the control group. No side effects were observed in any of the cases. In conclusion, surgeons applied VCM for cases which were invasive or had a high risk of infection. However, deep SSI was not observed in anyone in the VCM group. The intrawound administration of VCM might be effective to prevent SSI in cases with high risks of infection.
机译:手术部位感染(SSI)是脊柱手术中最严重的并发症之一。我们调查了有创脊柱手术后局部使用万古霉素(VCM)粉末预防SSI的功效。我们回顾性研究了174例接受脊柱手术的患者。在VCM组的患者(n = 81)中,在闭合伤口之前先在伤口中施用VCM粉末。将未接受VCM治疗的患者设为对照组(n = 93)。我们比较了两组患者的背景,手术时间,术中失血量,使用植入物,深SSI的存在以及副作用。年龄,性别和BMI在两组之间没有显着差异。 VCM组的手术时间和术中失血量比对照组更长和更大(分别为P <0.005,P <0.001)。 VCM组的85%和对照组的31%使用了植入物(P <0.001)。在VCM组中未观察到深SSI,而在对照组中有4例患者观察到了深SSI。在任何情况下均未观察到副作用。总之,外科医生将VCM用于有创或感染风险高的病例。但是,VCM组中的任何人都未观察到深度SSI。在感染风险高的情况下,VCM的伤口内给药可能有效预防SSI。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号